| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.29B | 62.70B | 66.68B | 64.61B | 50.61B | 45.06B |
| Gross Profit | 10.31B | 10.03B | 10.54B | 11.35B | 8.64B | 8.68B |
| EBITDA | 4.97B | 4.80B | 5.69B | 6.02B | 4.08B | 3.88B |
| Net Income | 1.59B | 1.53B | 2.43B | 2.60B | 1.37B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 51.66B | 50.12B | 46.43B | 46.50B | 39.69B | 36.22B |
| Cash, Cash Equivalents and Short-Term Investments | 245.00M | 241.00M | 214.00M | 411.00M | 198.00M | 177.00M |
| Total Debt | 11.46B | 10.73B | 7.90B | 11.09B | 7.60B | 5.01B |
| Total Liabilities | 22.84B | 21.69B | 22.10B | 23.81B | 18.64B | 16.30B |
| Stockholders Equity | 28.82B | 28.42B | 24.33B | 22.70B | 21.05B | 19.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.83B | 3.72B | -3.13B | -2.38B | 2.27B |
| Operating Cash Flow | 0.00 | 3.69B | 6.77B | -533.00M | 292.00M | 3.85B |
| Investing Cash Flow | 0.00 | -5.76B | -2.46B | -2.24B | -2.41B | -2.12B |
| Financing Cash Flow | 0.00 | 2.10B | -4.51B | 2.98B | 2.14B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥15.36B | 11.95 | ― | 2.16% | 1.28% | 18.81% | |
68 Neutral | ¥22.01B | 21.22 | ― | 1.74% | 7.66% | 2.64% | |
64 Neutral | ¥19.43B | 16.71 | ― | 2.98% | -0.73% | 23.36% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥38.28B | 12.29 | ― | 0.80% | 8.19% | 42.84% | |
59 Neutral | ¥13.93B | 34.48 | ― | 1.61% | 0.48% | -34.95% | |
46 Neutral | ¥37.25B | 311.33 | ― | 1.65% | -1.17% | -84.81% |